سعر سيناكتين ديبو 1مجم/مل أمبولة 2022

Tetracosactide (as acetate) 1 mg/ml depot suspension for intramuscular injection, adsorbed on zinc phosphate; 1 ampoule.

• Short-term therapy in glucocorticoid-responsive conditions (e.g. ulcerative colitis, Crohn disease, juvenile rheumatoid arthritis, adjunct in rheumatoid arthritis/osteoarthrosis), especially if oral glucocorticoids are not tolerated or ineffectivePopulation: Adults and children 3-12 yearsemc (MHRA)
• Diagnostic aid for investigation of adrenocortical insufficiency (5-hour depot test)Population: Adultsemc (MHRA)

• Hypersensitivity reactions and adrenal haemorrhage (frequency not known), plus effects of excess glucocorticoid/mineralocorticoid activity.International label, same product · emc (MHRA)

• Hypersensitivity to tetracosactide/ACTH; asthma or other allergies (anaphylaxis risk); acute psychoses, infections, Cushing syndrome, peptic ulcer, refractory heart failure, primary adrenocortical insufficiency, adrenogenital syndrome; intravenous use.International label, same product · emc (MHRA)

• Risk of hypersensitivity/anaphylaxis, usually within 30 minutes: give only under medical supervision with resuscitation available (adrenaline, steroids).International label, same product · emc (MHRA)
• Avoid in active infection, when live vaccines are planned or with reduced immune response; caution in ulcerative colitis, diverticulitis, recent intestinal anastomosis, kidney failure, hypertension, thromboembolism.International label, same product · emc (MHRA)

• Limited data in pregnancy; use only if expected benefit outweighs the potential risk to the foetus.International label, same product · emc (MHRA)
• Unknown whether excreted in human milk; use caution in breastfeeding women.International label, same product · emc (MHRA)